Skip to main content

International Cancer Conference Journal

Ausgabe 4/2023

Inhalt (14 Artikel)

Case Report - Diagnosis

Radiologic and pathologic correlation of a renal venous hemangioma

Alperen Elek, Jung Woo Kwon, Sena Ertugrul, Nisa Cem Oren

Case Report - Pathology

Myxoid liposarcoma in an 11-year-old patient

Tomoya Matsunobu, Akira Maekawa, Yuna Inaba, Kosuke Makihara, Masanori Hisaoka, Yukihide Iwamoto

Case Report - Pathology

Multidisciplinary management for primary uterine osteosarcoma, including gene panel testing: case report and literature review

Takako Kusanishi, Naotake Tanaka, Mizue Itoi, Miwa Ijiri, Keiko Ebisawa, Kiyomi Suzuka, Youko Hagiwara, Tukasa Yonemoto, Akinobu Araki, Makiko Itami

Case Report - Pathology

Successful management of a rare case of gallbladder neuroendocrine carcinoma with tumor thrombi

Bishal Pal, Souradeep Dutta, Debasis Naik, Sundaramoorthy Sudharsanan, Rajesh Nachiappa Ganesh, Vishnu Prasad Nelamangala Ramakrishnaiah

Case Report - Pathology

Neuroendocrine tumor of the minor duodenal papilla with lymph node metastasis: a case report and literature review

Hideo Ota, Shigekazu Yokoyama, Kazunori Yanagawa, Sadaharu Iio, Mutsumi Fukunaga

Case Report - Surgery

A rare case of pseudomyxoma peritonei with Morgagni hernia

Toru Imagami, Yasumitsu Oe, Byonggu An, Nobuyuki Takao, Takeshi Togawa, Akiyoshi Mizumoto

Case Report - Immunotherapy

Gastric neuroendocrine carcinoma presenting complete durable response by nivolumab treatment for multiple metastases and radiotherapy to oligoprogressive metastasis

Yusuke Seyama, Takeshi Yamada, Hirosumi Suzuki, Satoshi Fukuda, Miki Tsuji, Yusuke Niisato, Suguru Hirose, Yoshiyuki Yamamoto, Toshikazu Moriwaki, Ichinosuke Hyodo

Case Report - Immunotherapy

Successful multidisciplinary treatment with complete response to atezolizumab plus bevacizumab in a 90-year-old patient with hepatocellular carcinoma recurrence

Kiyotaka Hosoda, Takeo Toshima, Junichi Takahashi, Yusuke Yonemura, Yuichi Hisamatsu, Kosuke Hirose, Takaaki Masuda, Yushi Motomura, Tadashi Abe, Yuki Ando, Katsushi Dairaku, Yusuke Nakano, Masahiro Hashimoto, Yoshiki Hiraki, Yuji Soejima, Tomoharu Yoshizumi, Koshi Mimori

Case Report - Immunotherapy

A pathological complete response after immunotherapy with pembrolizumab for distal duodenal adenocarcinoma caused by Lynch syndrome: a case report

Shinichiro Ikeda, Qingjiang Hu, Keita Natsugoe, Tomoya Harima, Yasushi Tanaka, Izumi Kinoshita, Kentaro Nonaka, Sho Nambara, Ryota Nakanishi, Tomonori Nakanoko, Mitsuhiko Ota, Yasue Kimura, Eiji Oki, Yoshinao Oda, Tomoharu Yoshizumi

Case report-Molecularly targeted therapy

Intrahepatic cholangiocarcinoma with FGFR2 fusion gene positive that responded to pemigatinib and caused hypophosphatemia

Yoshinori Kikuchi, Kazuhisa Yamaguchi, Ryo Shimizu, Yuu Matsumoto, Yasuko Kurose, Naoki Okano, Yuichirou Otsuka, Kazutoshi Shibuya, Takahisa Matsuda, Hideaki Shimada

Case Report - Complication

A case of testicular seminoma with testicular abscess caused by Salmonella saintpaul

Yoshitsugu Nasu, Yuya Kawago

Case Report - Complication

A case series title: femoral nerve injury with an episode of motor neuropathy caused by gynecological surgery: a case series

Moyu Narita, Kazuhiro Suzuki, Keisuke Ogimoto, Keisuke Ichida, Junichi Aratake, Hiroshi Nakazawa, Takashi Shibutani, Miho Kitai, Takaya Shiozaki, Senn Wakahashi, Satoshi Yamaguchi

Case Report - Complication

Lethal ventricular arrhythmia due to entrectinib-induced Brugada syndrome: a case report and literature review

Keisuke Futamura, Tetsunari Hase, Akihito Tanaka, Yoshinori Sakai, Shotaro Okachi, Hirofumi Shibata, Futoshi Ushijima, Takahiko Hashimoto, Kuniya Nakashima, Katsuki Ito, Takanori Yamamoto, Atsushi Numaguchi, Yasuya Inden, Makoto Ishii

Case Report - Complication

Cardiac tamponade during pembrolizumab treatment in a patient with ovarian cancer: a case report

Wei-Ting Sung, Kunihiro Sakai, Haruka Etou, Rikiko Yamamichi, Tomoko Yoneda, Toshiaki Matsuura, Tomoyoshi Maruyama, Daisuke Nishi

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.